Dec 15, 2025 • Proactive financial news
SOMEWHAT-BULLISH
Just The Facts: Lindian Resources, Prescient Therapeutics, Tamboran Resources
This article highlights key developments for Lindian Resources, Prescient Therapeutics, and Tamboran Resources. Lindian Resources hosted US government officials at its rare earths project, emphasizing its role in critical mineral supply. Prescient Therapeutics received European authorization for its PTX-100 clinical trial, advancing its cancer therapy. Tamboran Resources completed stimulation of its Shenandoah South 6H well, preparing for production testing in early 2026.
Dec 10, 2025 • MarketBeat
NEUTRAL
Tamboran Resources Corporation (NYSE:TBN) Given Consensus Rating of "Moderate Buy" by Brokerages
Tamboran Resources Corporation (NYSE:TBN) has received a consensus "Moderate Buy" rating from seven brokerages, with an average 1-year target price of $36.40. This rating comes despite the company missing recent quarterly earnings estimates and reporting negative earnings, with a current market capitalization of approximately $525.3 million. Insiders and institutional investors are actively increasing their shares in the company, highlighting continued interest in Tamboran's future prospects.
Dec 09, 2025 • Investing.com
SOMEWHAT-BULLISH
Tamboran Resources elects directors and approves equity issuances at annual meeting
Tamboran Resources Corp (NYSE:TBN) held its 2025 Annual Meeting of Stockholders on December 4, where shareholders elected three Class II directors and ratified the appointment of Ernst & Young as their independent auditor. Shareholders also approved the issuance of equity compensation to Interim CEO Richard Stoneburner and other directors in lieu of fees. All proposals presented at the meeting were approved.
Dec 08, 2025 • Finviz
BULLISH
Tamboran Resources (TBN) Initiated by Analyst with a $35 Price Target
Wells Fargo initiated coverage of Tamboran Resources Corporation (NYSE:TBN) with an ‘Overweight’ rating and a price target of $35, indicating a significant upside potential. This initiation highlights Tamboran's three-phase development plan focusing on energy security in Northern Territory, Australia's East Coast gas market, and LNG exports to the Asia Pacific. The analyst also praised TBN's role as an international shale gas E&P in the undeveloped Beetaloo Basin.
Dec 06, 2025 • MarketBeat
SOMEWHAT-BULLISH
Tamboran Resources (NYSE:TBN) Now Covered by Analysts at Wells Fargo & Company
Wells Fargo & Company has initiated coverage on Tamboran Resources (NYSE:TBN) with an "overweight" rating and a $35.00 price target, suggesting a potential upside of 41.88%. This comes despite recent weak quarterly results where the company missed EPS estimates. Notably, there has been recent insider buying and increased institutional stakes in Tamboran Resources.
Dec 04, 2025 • MarketBeat
SOMEWHAT-BULLISH
Tamboran Resources (NYSE:TBN) Shares Gap Up - Here's What Happened
Tamboran Resources (NYSE:TBN) shares gapped up before market open on Tuesday, trading around $24.44 with a market cap near $497 million. This surge comes despite the company missing its quarterly earnings and revenue estimates, with analysts still projecting continued losses for the fiscal year. However, bullish analyst ratings from RBC and Wells Fargo, along with recent insider buying and increased institutional investor holdings, suggest underlying confidence in the stock.